(Q87798623)
Statements
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis (English)
Luca Prosperini
Floriana De Angelis
Rosanna De Angelis
Fulvia Fanelli